​
​

BeyondSpring (BYSI) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

BeyondSpring Revenue Highlights

Latest Revenue (Y)

$1.75M

Latest Revenue (Q)

$438.00K

BeyondSpring Revenue by Period

BeyondSpring Revenue by Year

DateRevenueChange
2023-12-31$1.75M29.61%
2022-12-31$1.35M-
2021-12-31$1.35M650.56%
2020-12-31$180.00K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--

BeyondSpring generated $1.75M in revenue during NA 2023, up 29.61% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

BeyondSpring Revenue by Quarter

DateRevenueChange
2023-12-31$438.00K-
2023-09-30$438.00K0.11%
2023-06-30$437.50K-
2023-03-31$437.50K29.63%
2022-12-31$337.50K-
2022-09-30$337.50K-0.15%
2022-06-30$338.00K-
2021-12-31$338.00K0.30%
2021-09-30$337.00K-0.30%
2021-06-30$338.00K-
2021-03-31$338.00K87.78%
2020-12-31$180.00K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31--

BeyondSpring generated $438.00K in revenue during Q4 2023, up 0.00% compared to the previous quarter, and up 129.78% compared to the same period a year ago.

BeyondSpring Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MCRBSeres Therapeutics$126.33M-
EYPTEyePoint Pharmaceuticals$46.02M$10.52M
OCUPOcuphire Pharma$19.05M$1.11M
SCPHscPharmaceuticals$13.59M$8.05M
KAKineta$5.44M-
BYSIBeyondSpring$1.75M$438.00K
MISTMilestone Pharmaceuticals$1.00M-
ADTXAditxt$645.18K$6.85K
LIFEaTyr Pharma$353.00K$235.00K
ALVRAlloVir--
FBRXForte Biosciences--
INKTMiNK Therapeutics--
RVPHReviva Pharmaceuticals--
ONCYOncolytics Biotech--
ONCTOncternal Therapeutics--
CADLCandel Therapeutics--
SLSSELLAS Life Sciences Group--
SRZNSurrozen--
KTTAPasithea Therapeutics--

BYSI Revenue FAQ

What is BeyondSpring’s yearly revenue?

BeyondSpring's yearly revenue for 2023 was $1.75M, representing an increase of 29.61% compared to 2022. The company's yearly revenue for 2022 was $1.35M, representing an increase of 0% compared to 2021. BYSI's yearly revenue for 2021 was $1.35M, representing an increase of 650.56% compared to 2020.

What is BeyondSpring’s quarterly revenue?

BeyondSpring's quarterly revenue for Q4 2023 was $438K, a 0% increase from the previous quarter (Q3 2023), and a 29.78% increase year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $438K, a 0.11% increase from the previous quarter (Q2 2023), and a 29.78% increase year-over-year (Q3 2022). BYSI's quarterly revenue for Q2 2023 was $437.5K, a 0% increase from the previous quarter (Q1 2023), and a 29.44% increase year-over-year (Q2 2022).

What is BeyondSpring’s revenue growth rate?

BeyondSpring's revenue growth rate for the last 3 years (2021-2023) was 29.61%, and for the last 5 years (2019-2023) was 0%.